case_images: PMC9024347_01
case_images: Cardiac MR images of Patient 1-4. Patient 1 with signs of a myopericarditis after mRNA SARS-CoV-2 vaccination with Spikevax (Moderna). Patient 2 with signs of a myocarditis after mRNA SARS-CoV-2 vaccination with Comirnaty (Pfizer-BioNTech). Patient 3 with signs of a discrete pericarditis in the LV-lateral area after SARS-CoV-2 vaccination with Janssen (Johnson and Johnson). Patient 4 with a mild to moderate pericardial effusion up to 11 mm in the medial posterior wall of the LV as a possible residual of an expired pericarditis/myocarditis after SARS-CoV-2 vaccination with Vaxzevria (AstraZeneca). SSFP, Stady state free precession; T2w FSE, T2-weighted fast spin echo; mDixon, Single breath-hold three-dimensional (3D) ECG-gated multi-echo chemical shift-based sequence; T1 relaxation were calculated from single breath-hold two-dimensional (2D) modified Look-Locker inversion recovery (MOLLI) sequence LA, long axis; SA, short axis.
case_images: fcvm-09-829392-g0001.jpg
case_images: PMC9024347_02_fcvm-09-829392-g0001.jpg
case_images: F1
case_images: T2 weighted images indicated a regional edema inferior/inferolateral (basal) with corresponding elevated quantitative myocardial T2 mapping parameters up to 53 ms (normal 35 to 51 ms at 3 Tesla) and corresponding subepicardial LGE in this region (Figure 1). The global T1 relaxation time (989 ms, normal 903 to 1985 ms at 1.5 Tesla) was normal.
case_images: PMC9024347_02
case_images: Cardiac MR images of Patient 1-4. Patient 1 with signs of a myopericarditis after mRNA SARS-CoV-2 vaccination with Spikevax (Moderna). Patient 2 with signs of a myocarditis after mRNA SARS-CoV-2 vaccination with Comirnaty (Pfizer-BioNTech). Patient 3 with signs of a discrete pericarditis in the LV-lateral area after SARS-CoV-2 vaccination with Janssen (Johnson and Johnson). Patient 4 with a mild to moderate pericardial effusion up to 11 mm in the medial posterior wall of the LV as a possible residual of an expired pericarditis/myocarditis after SARS-CoV-2 vaccination with Vaxzevria (AstraZeneca). SSFP, Stady state free precession; T2w FSE, T2-weighted fast spin echo; mDixon, Single breath-hold three-dimensional (3D) ECG-gated multi-echo chemical shift-based sequence; T1 relaxation were calculated from single breath-hold two-dimensional (2D) modified Look-Locker inversion recovery (MOLLI) sequence LA, long axis; SA, short axis.
case_images: fcvm-09-829392-g0001.jpg
case_images: PMC9024347_02_fcvm-09-829392-g0001.jpg
case_images: F1
case_images: T2 weighted images indicated a regional edema inferior/inferolateral (basal) with corresponding elevated quantitative myocardial T2 mapping parameters up to 53 ms (normal 35 to 51 ms at 3 Tesla) and corresponding subepicardial LGE in this region (Figure 1). The global T1 relaxation time (989 ms, normal 903 to 1985 ms at 1.5 Tesla) was normal.
case_images: PMC9024347_03
case_images: PMC9024347_04